Bausch & Lomb
Manufacturing · Canada · 10K+ Employees
View Company Info for Free
Overview
Headquarters
520 Applewood Cres, Vaughan, Ontario, L4...Phone Number
(905) 695-7601Website
www.bausch.comRevenue
$5.3 BillionStock Symbol
BLCOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
2
2
1
About Bausch & Lomb
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.Explore more
Bausch & Lomb Org Chart
CC
Vice President, Finance & Controller (America...
AC
Controller (Brazil)
RS
Controller
EP
Credit Controller (South Africa)
FC
Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bausch & Lomb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Bausch & Lomb, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Bausch & Lomb
Check if Bausch & Lomb has recently received funding, and reach out quickly before it becomes old news!
Check out if Bausch & Lomb is spiking on competitors!
Product Launch: Get notified when Bausch & Lomb launches new products
Funding: Get notified immidiatlly once Bausch & Lomb has new funding data
Earning: See what the market has to say on Bausch & Lomb recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Bausch & Lomb had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Explore company insights
Get a deeper look into Bausch & Lomb's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Bausch & Lomb is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bausch & Lomb is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bausch & Lomb.
Bausch & Lomb Tech Stack
A closer look at the technologies used by Bausch & Lomb
See more technologies
Most Recent Scoops
Earnings
Bausch & Lomb has reported Q2 Surgical segment revenue of $256 million, up 16% versus the prior year and up 17% versus the Q2 2024 pre-recall baseline, with implantables delivering 64% growth, premium IOLs growing 175%, consumables up 4%, and equipment revenue up 2%.
Earnings, Finance
Product Launch
Bausch & Lomb has launched Blink Triple Care Preservative Free in the US, with approximately 66% of its volume coming from new users to the franchise, contributing to 12% reported revenue growth for the broader Blink franchise in the quarter.
Product Launch, Sales
Earnings
Bausch & Lomb has reported that implantables grew 64% in Q2 on a constant currency basis and 37% versus the Q2 2024 pre-recall baseline, with premium IOLs as a percentage of surgical revenue increasing from 6% in 2023 to 13% in Q2 of the current year, reflecting a continued mix shift toward higher-margin products.
Earnings, Finance
Earnings
Bausch & Lomb has reported adjusted EBITDA of $246 million for Q2, up 28% year-over-year, with an adjusted EBITDA margin of 17.6%, driven by an accelerating mix shift toward premium IOLs in surgical and strong revenue growth from MIEBO and XIIDRA in pharmaceuticals.
Earnings, Pharmaceuticals, Finance
Earnings
Earnings, Pharmaceuticals, Finance
Bausch & Lomb News & Media
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
Sales projections exceed $2 billion if development and commercialization succeed; 68.2% of treated eyes had complete pain resolution versus 0% with vehicle.Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
VAUGHAN, Ontario, August 06, 2026--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its Board of Directors.Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"), today announced that its CEO, Thomas J. Appio, has been appointed to the board of directors of Bausch + Lomb Corporation (NYSE: BLCO)(TSX: BLCO), a subsidiary of...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Bausch & Lomb
Sign Up For FreeTo access detailed company insights
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, C... Read More
